Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis.

Geller, David E; Pitlick, William H; Nardella, Pasqua A; Tracewell, William G; Ramsey, Bonnie W

Geller, David E; Pitlick, William H; Nardella, Pasqua A; Tracewell, William G; Ramsey, Bonnie W.

Affiliation

Geller DE; Nemours Children's Clinic, Division of Pulmonology, Orlando, FL 32806, USA. dgeller@nemours.org

Chest ; 122(1): 219-26, 2002 Jul.

Article in En | MEDLINE | ID: mdl-12114362

Subject(s)

Anti-Bacterial Agents/therapeutic use; Cystic Fibrosis/drug therapy; Tobramycin/therapeutic use; Administration, Inhalation; Adolescent; Adult; Aerosols; Anti-Bacterial Agents/blood; Anti-Bacterial Agents/pharmacokinetics; Biological Availability; Child; Cystic Fibrosis/classification; Cystic Fibrosis/metabolism; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Randomized Controlled Trials as Topic; Severity of Illness Index; Tobramycin/blood; Tobramycin/pharmacokinetics; United States

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tobramycin / Cystic Fibrosis / Anti-Bacterial Agents Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Chest Year: 2002 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links